IT1089341B - 5- (SOST-FENIL) -OSSAZOLIDINONI AND THEIR ANALOGS OF THE SULFUR, AS WELL AS THE PROCEDURE FOR THEIR PREPARATION - Google Patents
5- (SOST-FENIL) -OSSAZOLIDINONI AND THEIR ANALOGS OF THE SULFUR, AS WELL AS THE PROCEDURE FOR THEIR PREPARATIONInfo
- Publication number
- IT1089341B IT1089341B IT30254/77A IT3025477A IT1089341B IT 1089341 B IT1089341 B IT 1089341B IT 30254/77 A IT30254/77 A IT 30254/77A IT 3025477 A IT3025477 A IT 3025477A IT 1089341 B IT1089341 B IT 1089341B
- Authority
- IT
- Italy
- Prior art keywords
- ossazolidinoni
- fenil
- sost
- analogs
- sulfur
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/16—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762655369 DE2655369A1 (en) | 1976-12-03 | 1976-12-03 | 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION |
| DE19772745320 DE2745320A1 (en) | 1977-10-05 | 1977-10-05 | 5-Alkoxyphenyl-oxazolidine-2-one and sulphur analogues - useful as neuroleptics and phospho-di:esterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IT1089341B true IT1089341B (en) | 1985-06-18 |
Family
ID=25771221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT30254/77A IT1089341B (en) | 1976-12-03 | 1977-12-01 | 5- (SOST-FENIL) -OSSAZOLIDINONI AND THEIR ANALOGS OF THE SULFUR, AS WELL AS THE PROCEDURE FOR THEIR PREPARATION |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5382777A (en) |
| AT (1) | AT357529B (en) |
| AU (1) | AU519994B2 (en) |
| CA (1) | CA1097657A (en) |
| CH (1) | CH635578A5 (en) |
| CS (1) | CS199694B2 (en) |
| DD (1) | DD133667A5 (en) |
| DK (1) | DK149850C (en) |
| FR (1) | FR2372814A1 (en) |
| GB (1) | GB1588639A (en) |
| GR (1) | GR64964B (en) |
| HU (1) | HU175676B (en) |
| IE (1) | IE46435B1 (en) |
| IL (1) | IL53520A (en) |
| IT (1) | IT1089341B (en) |
| LU (1) | LU78616A1 (en) |
| NL (1) | NL7713153A (en) |
| SE (1) | SE441446B (en) |
| SU (1) | SU888821A3 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2701215C2 (en) * | 1977-01-13 | 1982-10-14 | Bayer Ag, 5090 Leverkusen | Process for the preparation of thiazoline-2-thiones |
| US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
| DE3438839A1 (en) * | 1984-10-19 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | PHARMACEUTICAL PREPARATIONS |
| US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
| WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
| JPH01135098U (en) * | 1988-03-11 | 1989-09-14 | ||
| WO1991007177A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| US5461056A (en) * | 1992-05-08 | 1995-10-24 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
| GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
| GB9226830D0 (en) * | 1992-12-23 | 1993-02-17 | Celltech Ltd | Chemical compounds |
| US5622977A (en) * | 1992-12-23 | 1997-04-22 | Celltech Therapeutics Limited | Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same |
| GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| DE69433594T2 (en) * | 1993-12-22 | 2004-08-05 | Celltech R&D Ltd., Slough | TRISUBSTITUTED PHENYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AS PHOSPHODIESTERASE (TYPE IV) INHIBITORS |
| GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
| US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
| GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412571D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9622363D0 (en) | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
| AU5330698A (en) | 1996-12-23 | 1998-07-17 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9705361D0 (en) * | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
-
1977
- 1977-11-28 SU SU772546252A patent/SU888821A3/en active
- 1977-11-29 NL NL7713153A patent/NL7713153A/en not_active Application Discontinuation
- 1977-12-01 IT IT30254/77A patent/IT1089341B/en active
- 1977-12-01 DD DD7700202354A patent/DD133667A5/en unknown
- 1977-12-01 SE SE7713635A patent/SE441446B/en not_active IP Right Cessation
- 1977-12-01 LU LU78616A patent/LU78616A1/xx unknown
- 1977-12-02 CH CH1477977A patent/CH635578A5/en not_active IP Right Cessation
- 1977-12-02 GB GB50350/77A patent/GB1588639A/en not_active Expired
- 1977-12-02 AU AU31175/77A patent/AU519994B2/en not_active Expired
- 1977-12-02 DK DK536677A patent/DK149850C/en not_active IP Right Cessation
- 1977-12-02 IE IE2446/77A patent/IE46435B1/en not_active IP Right Cessation
- 1977-12-02 CA CA292,273A patent/CA1097657A/en not_active Expired
- 1977-12-02 JP JP14492277A patent/JPS5382777A/en active Granted
- 1977-12-02 HU HU77SCHE632A patent/HU175676B/en not_active IP Right Cessation
- 1977-12-02 GR GR54913A patent/GR64964B/en unknown
- 1977-12-02 IL IL53520A patent/IL53520A/en unknown
- 1977-12-05 CS CS778086A patent/CS199694B2/en unknown
- 1977-12-05 FR FR7736525A patent/FR2372814A1/en active Granted
- 1977-12-05 AT AT868677A patent/AT357529B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5382777A (en) | 1978-07-21 |
| DK149850C (en) | 1987-04-27 |
| FR2372814B1 (en) | 1980-10-10 |
| DK149850B (en) | 1986-10-13 |
| GB1588639A (en) | 1981-04-29 |
| GR64964B (en) | 1980-06-10 |
| IE772446L (en) | 1978-06-03 |
| AU3117577A (en) | 1979-06-07 |
| CS199694B2 (en) | 1980-07-31 |
| AU519994B2 (en) | 1982-01-07 |
| LU78616A1 (en) | 1978-04-20 |
| DD133667A5 (en) | 1979-01-17 |
| IE46435B1 (en) | 1983-06-15 |
| SE441446B (en) | 1985-10-07 |
| IL53520A0 (en) | 1978-03-10 |
| AT357529B (en) | 1980-07-10 |
| SE7713635L (en) | 1978-06-04 |
| CA1097657A (en) | 1981-03-17 |
| DK536677A (en) | 1978-06-04 |
| SU888821A3 (en) | 1981-12-07 |
| HU175676B (en) | 1980-09-28 |
| JPS6154792B2 (en) | 1986-11-25 |
| ATA868677A (en) | 1979-12-15 |
| IL53520A (en) | 1981-07-31 |
| FR2372814A1 (en) | 1978-06-30 |
| CH635578A5 (en) | 1983-04-15 |
| NL7713153A (en) | 1978-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1089341B (en) | 5- (SOST-FENIL) -OSSAZOLIDINONI AND THEIR ANALOGS OF THE SULFUR, AS WELL AS THE PROCEDURE FOR THEIR PREPARATION | |
| IT8019499A0 (en) | PROCEDURE TO IMPROVE THE FILLING CAPACITY OF TOBACCO. | |
| AR224095A1 (en) | PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF DITIOL-1,2 TIONA-3 | |
| IT1093049B (en) | PROCEDURE FOR THE PREPARATION OF I I I TRIFLUORO 2 2 DICHLOROETHANE | |
| DK382979A (en) | PROCEDURE FOR THE PREPARATION OF 3 ", 4" DIACYLYTYLOSINE DERIVATIVES | |
| MX4161E (en) | PROCEDURE FOR THE PREPARATION OF AMINO-ALCOXI-4 (2H) -PYRANONE-2,3-CONDENSATED SUBSTITUTES-5,62 | |
| FI793367A (en) | PROCEDURE FOR THE FRAMSTATION OF 1,2,3-THIADIAZOLE-5-YL-URINEEMNEN | |
| RO77485A (en) | PROCEDURE FOR THE PREPARATION OF 1,2,3-TIADIAZOL-3-IN-5-ILIDENDURES | |
| SE436026B (en) | PROCEDURE FOR THE PREPARATION OF 13,14-DEHYDROPROSTAGLANDINES | |
| SE423813B (en) | PROCEDURE FOR THE PREPARATION OF 1,5-DISUBSTITUTED PYRROLIDONS WITH THERAPEUTICAL PROPERTIES | |
| IT8048978A0 (en) | PROCEDURE FOR THE PRODUCTION OF THE ANTIBIOTIC CEFAMICIN C | |
| RO70629A (en) | PROCEDURE FOR THE PREPARATION OF 3,4-DIHYDRO-2-METHYL-4-OXO-2H-1,2-BENZOTIAZINE-3-CARBOXYLIC ACID 1,1-DIOXIDE | |
| RO75589A (en) | PROCEDURE FOR THE PREPARATION OF 2,6-METHAN-2H-1-BENZOXOXINE | |
| SE418225B (en) | PERISCOPE WITH TWO DOCTOR'S DOCTRINE | |
| IT1124897B (en) | AZOLYL-KETALS, PROCEDURE FOR THEIR PREPARATION AND USE WITH MICROBICIDES | |
| SE7707125L (en) | PROCEDURE FOR THE PREPARATION OF 7- (ALFA- (2,3, - DIHYDRO-2-OXO-1H- BENSIMIDAZOLE -1- YLCARBOMYL-AMINO) ARYLACETAMIDO) CEPHALASPORINES | |
| SE7804878L (en) | PROCEDURE FOR THE PREPARATION OF 1,2-DICHLORETANE | |
| ES493931A0 (en) | PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 3,4,5-TRIMETOXI-CINAMOIL-PIPERAZINE | |
| AR222075A1 (en) | PREPARATION PROCEDURE OF 2 ', 6'-DIALKYL-N-ALCOXYMETHYL-2-CHLORINE-ACETHANILIDE | |
| IT1158450B (en) | PROCEDURE FOR THE PREPARATION OF ERYTHRO-ALPHA-2-PIPERIDYL-2,8-BIS- (TRIFLUOROMETHYL) -4-QUINOLINMETHANOL | |
| ES494286A0 (en) | PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES 1,1,2-TRI- FENILPROPANOS AND -PROPENOS | |
| IT1125157B (en) | PROCEDURE FOR THE PREPARATION OF COMPOUNDS, '- ETHYLAROMATIC DIALOGEN | |
| NO772809L (en) | PROCEDURE FOR THE PREPARATION OF 2,6-DITERTI {RT-BUTYLPHENOL | |
| MX4690E (en) | PROCEDURE FOR THE PREPARATION OF ACID SULFIDE DERIVATIVES N.N'-BIS-CARBAMICO | |
| RO71255A (en) | PROCEDURE FOR THE PREPARATION OF 2,2-DIMETHYL-2,3-DIHYDROBENZOFURANIL-N-METHYL-N- (2-TOLUENESULPHONYL-METHYLAMINO-N'-SULPHENYL) |